Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
10/2003
10/23/2003US20030199435 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/23/2003US20030199423 ICAM-related protein
10/23/2003US20030199103 Novel amino acid sequences for human epidermal growth factor-like polypeptides
10/23/2003US20030199093 Retroviral packaging system, plasmids and packagable vector transcripts produced from high expression plasmids after stable or transient transfection in mammalian cells
10/23/2003US20030199071 Mutant E. coli FimH proteins and peptides that elicit antibodies that inhibit binding of FimH to mannose than antibodies elicited by wild type FimH
10/23/2003US20030199064 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/23/2003US20030199063 PRO polypeptides; fused to heterologous polypeptide sequences
10/23/2003US20030199062 PRO polypeptides; fused to heterologous polypeptide sequences
10/23/2003US20030199061 PRO polypeptides; fused to heterologous polypeptide sequences
10/23/2003US20030199060 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/23/2003US20030199059 PRO polypeptides; fused to heterologous polypeptide sequences
10/23/2003US20030199058 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/23/2003US20030199057 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/23/2003US20030199056 PRO polypeptides; fused to heterologous polypeptide sequences
10/23/2003US20030199055 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/23/2003US20030199054 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/23/2003US20030199053 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/23/2003US20030199052 PRO polypeptides; fused to heterologous polypeptide sequences
10/23/2003US20030199051 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/23/2003US20030199043 Therapeutic proteins (including polypeptide, antibody, peptide or fragment or variants)fused to albumin or fragment or variant linked by a linker peptide; nonglycosylated
10/23/2003US20030199042 Novel morphogenic protein
10/23/2003US20030199033 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/23/2003US20030199032 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/23/2003US20030199031 A PRO polypeptide having a full-length amino acid sequence fused to heterologous polypeptide sequences
10/23/2003US20030199030 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/23/2003US20030199029 A PRO polypeptide having a full-length amino acid sequence fused to heterologous polypeptide sequences
10/23/2003US20030199028 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/23/2003US20030199027 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/23/2003US20030199026 A PRO polypeptide having a full-length amino acid sequence fused to heterologous polypeptide sequences
10/23/2003US20030199025 A PRO polypeptide having a full-length amino acid sequence fused to heterologous polypeptide sequences
10/23/2003US20030199023 A PRO polypeptide having a full-length amino acid sequence fused to heterologous polypeptide sequences
10/23/2003US20030199013 A preferred synthetic polypeptide having at least one antigenic site of a prion protein which only exist in nervous tissue of a mammal suffering from spongiform encephalopathy
10/23/2003US20030199009 Modifications of apoptin
10/23/2003US20030198998 Compositions, methods and kits for immunochemical determination of mannan-binding lectin (MBL)
10/23/2003US20030198994 Identification and isolation of novel DNA and the recombinant production of novel polypeptides encoded by that DNA
10/23/2003US20030198993 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/23/2003US20030198989 For use as a diagnostic reagent for detecting the presence or absence of a target molecule in a sample; Systematic Evolution of Ligands by EXponential enrichment (SELEX)
10/23/2003US20030198986 Differential screening of a rat hippocampus cDNA library; a cDNA species encoding a novel protein designated Hct-1 is shown to be related to cytochromes P450
10/23/2003US20030198975 Proteins associated with cell growth, differentiation, and death
10/23/2003US20030198970 Genostics
10/23/2003US20030198966 Displacement assay for detection of small molecules
10/23/2003US20030198956 Staged assembly of nanostructures
10/23/2003US20030198954 For forensic analyses, chromosome tissue/cell/organelle-specific markers, production of expression vectors, screening and diagnosis assays
10/23/2003US20030198953 For diagnosis, treatment, and prevention of related disorders
10/23/2003US20030198949 Viral polypeptides that regulate or modulate apoptosis
10/23/2003US20030198947 Hepatitis virus sentinel virus I (SVI)
10/23/2003US20030198946 Hepatitis-C virus testing
10/23/2003US20030198939 In vitro culturing of monocytes in presence of monoclonal antibody
10/23/2003US20030198681 Method of making a protein polymer and uses of the polymer
10/23/2003US20030198647 Rheumatic diseases; autoimmune disease
10/23/2003US20030198644 HCV peptide antigens and methods for the determination of HCV
10/23/2003US20030198641 Immunoassay, immunotherapy; antiinflammatory agents; anticancer agents
10/23/2003US20030198640 Methods and compositions for treating inflammatory bowel diseases relating to human tumor necrosis factor-gamma-beta
10/23/2003US20030198639 Methods of treating sickle cell disease
10/23/2003US20030198638 Tumor specific monoclonal antibodies
10/23/2003US20030198637 Antiproliferative agent; induction apoptosis; antitumor agents
10/23/2003US20030198636 Prevent completitive binding; amplification inflammation response; convertase inhibitor; side effect reduction
10/23/2003US20030198635 Treatment of ulcerative colitis with tropomyosin isoforms and monoclonal antibodies to tropomyosin isoforms
10/23/2003US20030198634 Methods of treating joint inflammation with chimeric anti-TNF antibodies
10/23/2003US20030198628 Harvesting pancrea tissue; grafting into body cavity; increase insulin concentration
10/23/2003US20030198595 Completitive binding
10/23/2003CA2482938A1 Antibodies that specifically bind to tr2
10/23/2003CA2482718A1 Derivatives of the il-2 receptor gamma chain, their production and use
10/23/2003CA2482658A1 Compositions, methods and kits for immunochemical determination of mannan-binding lectin (mbl)
10/23/2003CA2482634A1 Diagnostic and therapeutic use of kremen 1 and 2, inhibitors of the canonical wnt-signal transduction
10/23/2003CA2482387A1 Derivatives of the nf-kappab inducing enzyme, their preparation and use
10/23/2003CA2481922A1 Antibodies that bind to integrin alpha-v-beta-6 and methods of use thereof
10/23/2003CA2481895A1 Methods and reagents for assaying protein kinase activity
10/23/2003CA2481827A1 Polyvalent cation-sensing receptor in atlantic salmon
10/23/2003CA2481813A1 Antibody gene transfer and recombinant aav therefor
10/23/2003CA2481796A1 Binding agents and their use in targeting tumor cells
10/23/2003CA2481747A1 Recombinant anti-interleukin-9 antibodies
10/23/2003CA2481515A1 Anti-her2 antibody variants
10/23/2003CA2481509A1 Her-2 receptor tyrosine kinase molecules and uses thereof
10/23/2003CA2481508A1 G-protein coupled receptor ligands and methods
10/23/2003CA2481503A1 Nucleic acid and corresponding protein entitled 98p4b6 useful in treatment and detection of cancer
10/23/2003CA2481207A1 Methods of treatment using ctla-4 antibodies
10/23/2003CA2481087A1 Compositions and methods for the diagnosis and treatment of herpes simplex virus infection
10/23/2003CA2481074A1 Human anti-opgl neutralizing antibodies as selective opgl pathway inhibitors
10/23/2003CA2481042A1 Mycoplasma polypeptides
10/23/2003CA2480745A1 Methods for treating tweak-related conditions
10/23/2003CA2479835A1 An ephrin-b receptor protein involved in carcinoma
10/22/2003EP1355158A1 Method for diagnosing inflammatory and infectious diseases by detecting the phosphoprotein LASP-1 as inflammation marker
10/22/2003EP1355152A1 Compositions for diagnosis and therapy of diseases associated with aberrant expression of kremen
10/22/2003EP1354950A1 Nf-kb activating gene
10/22/2003EP1354943A2 Monoclonal antibodies, hybridomas, cell isolation method, isolated cells and immunological diagnostic method
10/22/2003EP1354896A1 Novel monoclonal antibody
10/22/2003EP1354600A1 Antibody combination useful for tumor therapy
10/22/2003EP1354598A2 Therapeutic uses of BR43X2 soluble receptors
10/22/2003EP1354199A2 Diagnosis and treatment of multiple sclerosis
10/22/2003EP1354054A2 Polypeptides capable of binding to cd64 and comprising one or more heterologous t cell epitopes, and their uses
10/22/2003EP1354048A2 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
10/22/2003EP1354047A2 Methods for screening compounds that modulate lipid metabolism
10/22/2003EP1354046A2 A member of the lysyl oxidase gene family
10/22/2003EP1354043A2 Sequences involved in phenomena of tumour suppression, tumour reversion, apoptosis and/or virus resistance and their use as medicines
10/22/2003EP1354042A2 Proteins and nucleic acids encoding same
10/22/2003EP1354040A2 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/22/2003EP1354034A2 Transgenic transchromosomal rodents for making human antibodies
10/22/2003EP1353955A2 High affinity antibodies
10/22/2003EP1353954A2 Anticoagulants and their uses
1 ... 874 875 876 877 878 879 880 881 882 883 884 885 886 887 888 889 890 891 892 893 894 ... 1494